Abstract: The present invention pertains to: a self-priming and replicating hairpin adaptor for constructing an NGS (next generation sequencing) library; and a method for constructing an NGS library using the same. Specifically, the present invention pertains to: a self-priming and replicating hairpin adaptor for constructing an NGS library, the adaptor containing a long single-stranded first oligonucleotide that comprises a nucleotide sequence of SEQ ID NO: 4 and has a hairpin structure, and a short single-stranded second oligonucleotide that comprises a nucleotide sequence of SEQ ID NO: 5; a method for constructing an NGS library using said adaptor; and an NGS library construction kit including said adaptor.

Abstract: A superconducting quantum interferometric device (SQUID) includes: a conductive material region formed on a partial region of a substrate; a first superconducting material layer including a first loop including first and second extension units that are spaced apart from each other to form a proximity Josephson junction and that form a stack structure with the conductive material region; a second superconducting material layer including a second loop including first and second end units spaced apart from each other; and a tunnel Josephson junction formed by a stack structure including a tunnel thin film layer forming and the first and second end units, wherein at least a portion of the second loop forms a stack structure with the first loop.

Abstract: There is provided with a method for treating cancer, comprising administering a pharmaceutical composition to a patient with cancer in combination with an anti-cancer agent, the pharmaceutical composition. A compound is represented by General Formula (I) or a pharmaceutically acceptable salt thereof: where R1 is an acyl residue from a fatty acid.

Abstract: A visualization fluid composition is provided to enhance visualization and analysis of samples. The visualization fluid composition includes a low molecular weight ester, ether, or formate moiety, a volatile organic liquid chemical component, stabilization components, preservation components; and an image color adjusting moiety.

Abstract: Devices and systems for performing an operation are provided. The system comprises a mobile platform comprising a frame having side supports and a rear support, side wheel assemblies coupled to the side supports, and a rear wheel assembly coupled to the rear support. The wheel assemblies each comprise wheels and a wheel frame, the wheel frame being pivotally connected to the side and rear supports. The system further comprises a first control system for controlling movement of the mobile platform and a manipulator element coupled to the mobile platform. The manipulator element is configured to removably connect to the mobile platform and to perform an operation. The manipulator element comprises a second control system for controlling the operation. The first control system and the second control system are configured to communicate to cause the mobile platform to move and to cause the manipulator element to perform the operation.

Abstract: An operating method of an access point (AP) multi-link device (MLD) is provided. The operating method includes: based on at least one non-AP MLD and at least one single link device (SLD) attempting channel access through a first link of the AP MLD, identifying a contention window of the at least one non-AP MLD, based on a ratio of, with respect to the first link, an idle time of the at least one non-AP MLD to an idle time of the at least one SLD; and transmitting a beacon frame including information about the contention window to the at least one non-AP MLD.

Abstract: An optical display system and a head-mounted display electronics apparatus are disclosed. The optical display system comprises: an image-generating apparatus, which generates image light; and an image-viewing apparatus, which guides the image light to eyes of a viewer, wherein the image-viewing apparatus comprises an imaging optical assembly and a multifocal assembly placed, the multifocal assembly has at least two optical powers and is programmable to choose at least one of the optical powers at a given time.

Abstract: Provided are a content caching optimization system and method. The content caching optimization system in which content priority in an information-centric networking (ICN) environment is taken into consideration includes one or more producer terminals configured to generate and provide content, one or more user terminals configured to transmit content requests according to users and receive content according to the content requests, one or more mobilelmultiple access edge cotnputings (MECs) configured to predict the number of requests for each piece of content to be requested later on the basis of the content requests received from the user terminals, and a software-defined network (SDN) controller configured to calculate a content popularity using the number of requests for each piece of content predicted by the MECs and perform content caching optimization on the basis of the calculated content popularity and a preset content priority.

Abstract: One embodiment of the present invention provides a flame doping method. Specifically, the present invention provides a flame doping method, which does not significantly change crystallinity, does not damage a substrate even while applying a high temperature, is usable as a doping method suitable for mass production, is advantageous in a process difficulty and a cost compared to other doping processes (thermal diffusion and ion implantation), and has high process stability.

Abstract: The present invention relates to a chemical and biological integrated degradation process for PET, for recycling PET, and, more specifically, the present invention provides a PET upcycling technique for producing a high-value product via a chemical pretreatment process of PET, a TPA and EG production process using an enzyme, and a process for converting TPA and EG to PCA and GLA, respectively.

Abstract: The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.

Abstract: A voice signal estimation apparatus using attention mechanism according to an embodiment may comprise a microphone encoder that receives a microphone input signal including an echo signal, and a user's voice signal, converts the microphone input signal into first input information, and outputs the converted first input information, a far-end signal encoder that receives a far-end signal, converts the far-end signal into second input information, and outputs the converted second input information, an attention unit outputting weight information by applying an attention mechanism to the first input information and the second input information, a pre-learned first artificial neural network with third input information, which is the sum information of the weight information and the second input information, as input information, and with first output information including mask information for estimating the voice signal from the second input information as output information and a voice signal estimator outputtin

Abstract: Genetically modified CCNT1 and XPO1 genes encoding proteins that inhibit virus infection in cells. The genetically modified CCNT1 gene encodes a protein with a C261Y substitution with respect to the human CCNT1 protein. The genetically modified XPO1 gene encodes a protein with P411T, M412V, and/or F414S substitutions with respect to the human XPO1 protein. The genetically modified CCNT1 and XPO1 genes can be introduced in cells. The cells comprising the genetically modified CCNT1 and XPO1 genes can be introduced in a subject with a virus infection to treat the infection.

Abstract: One embodiment of the present invention provides a method of manufacturing an electronic device using a cyclic doping process including i) an operation of forming a unit transfer thin film including a two-dimensional material on a transfer substrate, ii) an operation of doping the unit transfer thin film in a low-damage doping process, iii) an operation of transferring the unit transfer thin film doped according to the operation ii) on a transfer target substrate, and iv) an operation of repeatedly performing the operations i) to iii) several times to reach a target thickness.

Abstract: A device including processors configured to execute instructions and memories storing the instructions, which when executed by the processors configure the processors to perform an operation for training a transformer model having a plurality of encoders and a plurality of decoders by configuring the processors to identify the batches of training data into a plurality of micro-batches, select layer pairs for the plurality of micro-batches, assemble a processing order of the layer pairs, determining resource information to be allocated to the layer pairs, and allocate resources to the layer pairs based on the determined resource information to be allocated to the layer pairs, dependent con the processing order of the layer pairs.

Abstract: Proposed are pharmaceutical compositions and health functional foods containing a Ganoderma lucidum fruiting body extract as an active ingredient for preventing, treating, or ameliorating thrombosis. The extract exhibits strong antithrombotic activity by inhibiting thrombosis-related enzymes and blood coagulation factors, has excellent thermal stability, and exhibits no loss of blood coagulation factor inhibitory effect and thrombogenic enzyme inhibitory effect even in acidic conditions of pH 2 and in plasma. Therefore, the Ganoderma lucidum fruiting body extract is expected to be used for the prevention and treatment of thrombosis, which causes ischemic stroke and hemorrhagic stroke, by improving blood circulation. The Ganoderma lucidum fruiting body extract is very useful in the pharmaceutical and food industries.

Abstract: The disclosed technology relates to redox flow batteries (“RFB”), and particularly to electrolytes useful in RFBs based on 2,5-dimercapto-1,3,4-thiadiazole (“DMTD”) and derivatives thereof.

Abstract: A quality assurance device for a medical accelerator includes a housing having an inner radioluminescent layer adapted to provide a visual indication when contacted with invisible radiation generated by the medical accelerator. In addition, the quality assurance device includes one or more cameras located within the housing and adapted to image the inner radioluminescent layer of the housing including the visual indication.

Abstract: A handover method, performed by a source base station in a wireless communication system, includes: receiving an indicator indicating a start of packet duplication transmission of a user plane function (UPF); and transmitting at least one redundant packet to a target base station, based on the indicator indicating the start of the packet duplication transmission of the UPF, wherein the packet duplication transmission includes transmitting, to the target base station, a packet that is identical to a packet transmitted by the UPF to the source base station, wherein the redundant packet includes a packet that was received from the UPF before the start of the packet duplication transmission but is not transmitted to a User Equipment (UE) and stored.

Abstract: Described herein are various embodiments of a valve that may be opened and closed using a thixotropic or “stress yield” material, or other material that temporarily changes phase upon application of energy to the material. More particularly, some embodiments may include a valve that is opened and closed using a granular gel that is a temporary phase change material.